SCHEMBL13626133

SCHEMBL13626133

CCc1sc(C(=O)Nc2cc(-c3cn(C)c(=O)c(Nc4ccc(C5CCN(C)CC5)cc4)n3)ccc2F)cc1C(C)C

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BTK Q06187 20/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13626831 0.84 BTK (0.51) BTK
SCHEMBL1784132 0.83 BTK (0.59) BTK
SCHEMBL13626827 0.83 BTK (0.47) BTK
SCHEMBL13626129 0.83 BTK (0.47) BTK
SCHEMBL13626377 0.80 CDK6 (0.45) BTK
SCHEMBL13626131 0.80 BTK (0.43) BTK
SCHEMBL13626128 0.78 BTK (0.41) BTK
SCHEMBL13626122 0.77 BTK (0.55) BTK
SCHEMBL13626485 0.77 SYK (0.47) BTK
SCHEMBL13626188 0.77 CDK6 (0.45) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009137596-A1 SUBSTITUTED AMIDES, METHOD OF MAKING, AND USE AS BTK INHIBITORS CGI PHARMACEUTICALS, INC. (US) 2009-11-12 WO disclosed